Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 41:2004-2009, doi:10.1016/S0735-1097(03)00421-2
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ammann, P.
Right arrow Articles by Fehr, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ammann, P.
Right arrow Articles by Fehr, T.

Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes

Peter Ammann, MD*,*,1, Marco Maggiorini, MD{ddagger}, Osmund Bertel, MD*, Edgar Haenseler, MD§, Helen I. Joller-Jemelka, MD||, Erwin Oechslin, MD, Elisabeth I. Minder, MD{dagger}, Hans Rickli, MD and Thomas Fehr, MD{ddagger}

* Division of Cardiology, Triemli Hospital, Zurich, Switzerland
{dagger} Central Laboratory, Triemli Hospital, Zurich, Switzerland
{ddagger} Intensive Care Unit of the Department of Internal Medicine, Zurich, Switzerland
§ Institute of Clinical Chemistry, Zurich, Switzerland
|| Division of Clinical Immunology, University Hospital, Zurich, Switzerland
Division of Cardiology, University Hospital, Zurich, Switzerland



View larger version (27K):

[in a new window]
 
Figure 1 Kaplan-Meier survival analysis of troponin-positive and -negative patients. (A) The overall 30-day mortality was significantly higher in troponin-positive (n = 32) than in troponin-negative (n = 26) patients (p = 0.018). (B) When subgroups of patients with volume-refractory shock needing catecholamine therapy (n = 24) and patients without shock (n = 34) were analyzed separately, a significant difference in mortality was found in the subgroup without shock only (p = 0.03). ns = not significant.

 


View larger version (21K):

[in a new window]
 
Figure 2 Relationship between left ventricular ejection fraction (LVEF) and peak cardiac troponin I (cTnI) level. A significantly lower LVEF was found in troponin-positive versus -negative patients (r = 0.44, p = 0.0006). All patients with LVEF <45% (left of thin vertical line) had sepsis or septic shock, and 11 of 13 were troponin-positive. The normal cutoff level for cTnI is indicated at 0.1 µg/l by a bold horizontal line.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement